Q3 2024 · 13F-HR
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2024-11-14 · accession 0001012975-24-000488
$4.73B
Reported value
108
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $324.7M | 6.87% | 3,888,669 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $304.8M | 6.45% | 2,979,235 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $299.7M | 6.34% | 28,057,456 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $249.9M | 5.29% | 26,617,709 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $231.7M | 4.90% | 2,027,608 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $186.5M | 3.95% | 3,560,214 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $181.7M | 3.84% | 6,315,933 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $161.8M | 3.42% | 3,204,976 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $118.7M | 2.51% | 1,622,215 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $118.4M | 2.50% | 2,015,007 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $107.6M | 2.28% | 1,699,987 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $100.5M | 2.13% | 6,282,290 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $92.3M | 1.95% | 8,086,159 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $86.8M | 1.84% | 5,356,622 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $84.5M | 1.79% | 2,872,547 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $74.4M | 1.57% | 2,793,703 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $74.2M | 1.57% | 1,485,232 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $71.4M | 1.51% | 6,485,420 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $70.4M | 1.49% | 782,844 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $68.0M | 1.44% | 8,005,000 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $68.0M | 1.44% | 3,683,004 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $67.8M | 1.43% | 2,378,762 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $67.0M | 1.42% | 1,164,035 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $64.4M | 1.36% | 118,839 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $64.0M | 1.35% | 2,812,665 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $62.2M | 1.32% | 2,330,294 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $61.9M | 1.31% | 1,374,563 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $52.4M | 1.11% | 12,581,103 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $50.0M | 1.06% | 9,275,851 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $49.2M | 1.04% | 1,714,806 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $48.1M | 1.02% | 6,906,646 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $42.6M | 0.90% | 1,296,416 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $39.5M | 0.84% | 400,000 | PUT | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $37.5M | 0.79% | 5,360,858 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $37.0M | 0.78% | 724,698 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $35.9M | 0.76% | 12,594,211 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $35.2M | 0.75% | 2,362,279 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $33.1M | 0.70% | 142,269 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $30.3M | 0.64% | 1,235,187 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $29.0M | 0.61% | 1,516,668 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $28.9M | 0.61% | 3,324,468 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $28.6M | 0.60% | 58,119 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $27.9M | 0.59% | 220,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $27.7M | 0.59% | 733,695 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $27.4M | 0.58% | 2,180,020 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $25.8M | 0.55% | 718,144 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $25.3M | 0.54% | 9,812,419 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $25.3M | 0.54% | 1,027,749 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $25.3M | 0.54% | 315,659 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $24.5M | 0.52% | 212,228 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $23.6M | 0.50% | 4,592,556 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $23.3M | 0.49% | 345,545 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $22.5M | 0.48% | 429,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $22.2M | 0.47% | 692,263 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $22.1M | 0.47% | 245,332 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $21.2M | 0.45% | 1,060,200 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $20.7M | 0.44% | 524,930 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $19.4M | 0.41% | 1,144,035 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $19.0M | 0.40% | 387,017 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $17.2M | 0.36% | 931,851 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $16.7M | 0.35% | 1,064,026 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $15.3M | 0.32% | 748,183 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $15.0M | 0.32% | 300,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.1M | 0.28% | 180,000 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $12.7M | 0.27% | 44,353 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $12.6M | 0.27% | 1,358,500 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $12.1M | 0.26% | 1,410,438 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $12.0M | 0.25% | 511,226 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $10.6M | 0.22% | 527,671 | Common | SOLE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $10.3M | 0.22% | 7,099,182 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $9.8M | 0.21% | 847,745 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $9.8M | 0.21% | 415,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $8.5M | 0.18% | 125,000 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $8.3M | 0.18% | 1,037,274 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $7.6M | 0.16% | 2,725,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.2M | 0.15% | 250,000 | PUT | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.2M | 0.15% | 250,000 | CALL | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $6.9M | 0.15% | 2,125,649 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $5.8M | 0.12% | 255,994 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $5.6M | 0.12% | 7,283,157 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $5.4M | 0.11% | 183,000 | PUT | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $5.4M | 0.11% | 1,500,000 | CALL | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.2M | 0.11% | 500,000 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $3.9M | 0.08% | 2,173,880 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $3.8M | 0.08% | 426,293 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.4M | 0.07% | 815,722 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $3.3M | 0.07% | 12,757,562 | Common | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $3.2M | 0.07% | 555,066 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $2.7M | 0.06% | 700,000 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $2.4M | 0.05% | 5,402,964 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $2.4M | 0.05% | 3,545,454 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $2.3M | 0.05% | 694,315 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $2.2M | 0.05% | 46,213 | Common | SOLE |
| 896438504 | TRIB | TRINITY BIOTECH PLC | $2.0M | 0.04% | 1,800,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $1.9M | 0.04% | 508,462 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $1.7M | 0.04% | 22,591 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.5M | 0.03% | 34,852 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.3M | 0.03% | 139,835 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $1.3M | 0.03% | 100,000 | PUT | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $1.2M | 0.03% | 345,575 | Common | SOLE |
| 82933R308 | — | SINGULAR GENOMICS SYSTEMS IN | $797,540 | 0.02% | 50,896 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $733,500 | 0.02% | 150,000 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $535,198 | 0.01% | 95,742 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $251,021 | 0.01% | 116,754 | Common | SOLE |
| 14171W202 | — | CAREMAX INC | $170,000 | 0.00% | 100,000 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $35,000 | 0.00% | 250,000 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $1,717 | 0.00% | 166,666 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $594 | 0.00% | 60,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.